C1-esterase inhibitor - BioGenius

Drug Profile

C1-esterase inhibitor - BioGenius

Alternative Names: Bicizar; Human plasma derived C1-esterase inhibitor; Human purified derived C1-esterase inhibitor

Latest Information Update: 27 Nov 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator BioGenius
  • Class
  • Mechanism of Action Complement C1 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Sepsis; Septic shock

Most Recent Events

  • 26 Nov 2015 BioGenius' C1-esterase inhibitor is still at the phase III stage of development in Russia
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top